The Arcady Group Founder presented at the WHO Symposium: “Digital Health Technology for the End TB Strategy.” The presentation entitled “New Approaches to Adherence Support for TB Care: The Future Is Now,” outlined alternatives to witnessed dosing for improving patient adherence and enabling differentiated care. Contents include a model for adherence improvement from treatment initiation to cure, overview of available monitoring technologies, and findings to date from trials and evaluations underway in India and China.
Resource not currently available.